Parkinson’s stem cell therapy demonstrates promise in Phase II trial
The Hope Biosciences Research Foundation (HBRF) is eyeing a Phase III confirmatory trial for its stem cell therapy after the…
News
AstraZeneca’s NSCLC combo fails to meet primary endpoint in Phase III trial
AusperBio concludes enrolment in Phase III AUSHINE trial
South Korea and Australia offer solutions for radiopharma trial bottlenecks
Neurocrine’s Phase III trial of valbenazine for DCP fails to meet endpoints
UAE positions itself as a regional leader and a clinical trial hub
Ipsen’s ultra-rare bone disease drug flops in Phase II trial
Psyence gains HREC nod to use PsyLabs’ psilocybin in adjustment disorder trial
